BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25759289)

  • 21. Therapeutic effects of serelaxin in acute heart failure.
    Du XJ; Hewitson TD; Nguyen MN; Samuel CS
    Circ J; 2014; 78(3):542-52. PubMed ID: 24451687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF.
    Liu LC; Voors AA; Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Chen Y; Greenberg BH; Ponikowski P; Pang PS; Prescott MF; Hua TA; Severin TM; Metra M
    Clin Res Cardiol; 2016 Sep; 105(9):727-37. PubMed ID: 27017514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study.
    Cotter G; Voors AA; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Milo O; Hua TA; Qian M; Severin TM; Teerlink JR; Metra M; Davison BA
    Eur J Heart Fail; 2015 Nov; 17(11):1133-43. PubMed ID: 26333529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relaxin, a pleiotropic vasodilator for the treatment of heart failure.
    Teichman SL; Unemori E; Dschietzig T; Conrad K; Voors AA; Teerlink JR; Felker GM; Metra M; Cotter G
    Heart Fail Rev; 2009 Dec; 14(4):321-9. PubMed ID: 19101795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serelaxin for the treatment of heart failure.
    Moin DS; Bloom MW; Papadimitriou L; Butler J
    Expert Rev Cardiovasc Ther; 2016 Jun; 14(6):667-75. PubMed ID: 27045761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Serelaxin in Patients with Acute Heart Failure.
    Metra M; Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Voors AA; Adams KF; Anker SD; Arias-Mendoza A; Avendaño P; Bacal F; Böhm M; Bortman G; Cleland JGF; Cohen-Solal A; Crespo-Leiro MG; Dorobantu M; Echeverría LE; Ferrari R; Goland S; Goncalvesová E; Goudev A; Køber L; Lema-Osores J; Levy PD; McDonald K; Manga P; Merkely B; Mueller C; Pieske B; Silva-Cardoso J; Špinar J; Squire I; Stępińska J; Van Mieghem W; von Lewinski D; Wikström G; Yilmaz MB; Hagner N; Holbro T; Hua TA; Sabarwal SV; Severin T; Szecsödy P; Gimpelewicz C;
    N Engl J Med; 2019 Aug; 381(8):716-726. PubMed ID: 31433919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actions.
    Díez J
    Am J Cardiovasc Drugs; 2014 Aug; 14(4):275-85. PubMed ID: 24590581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU.
    Maggioni AP; López-Sendón J; Nielsen OW; Hallén J; Aalamian-Mattheis M; Wang Y; Ertl G
    Eur J Heart Fail; 2019 Mar; 21(3):322-333. PubMed ID: 30604559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relaxin' the Heart: A Novel Therapeutic Modality.
    Raleigh JM; Toldo S; Das A; Abbate A; Salloum FN
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):353-62. PubMed ID: 26589290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.
    Teerlink JR; Metra M; Felker GM; Ponikowski P; Voors AA; Weatherley BD; Marmor A; Katz A; Grzybowski J; Unemori E; Teichman SL; Cotter G
    Lancet; 2009 Apr; 373(9673):1429-39. PubMed ID: 19329178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2.
    Loungani RS; Teerlink JR; Metra M; Allen LA; Butler J; Carson PE; Chen CW; Cotter G; Davison BA; Eapen ZJ; Filippatos GS; Gimpelewicz C; Greenberg B; Holbro T; Januzzi JL; Lanfear DE; Pang PS; Piña IL; Ponikowski P; Miller AB; Voors AA; Felker GM
    JACC Heart Fail; 2020 Dec; 8(12):999-1008. PubMed ID: 33189635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of serelaxin in patients admitted for acute heart failure: a meta-analysis.
    Teerlink JR; Davison BA; Cotter G; Maggioni AP; Sato N; Chioncel O; Ertl G; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Edwards C; Senger S; Teichman SL; Nielsen OW; Voors AA; Metra M
    Eur J Heart Fail; 2020 Feb; 22(2):315-329. PubMed ID: 31886953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relaxin: a new approach for the treatment of acute congestive heart failure.
    Grossman J; Frishman WH
    Cardiol Rev; 2010; 18(6):305-12. PubMed ID: 20926940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relaxin for treatment of acute heart failure: making the case for treating targeted patient profiles.
    Hernandez-Montfort JA; Arora S; Slawsky MT
    Curr Heart Fail Rep; 2013 Sep; 10(3):198-203. PubMed ID: 23836112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial.
    Pang PS; Teerlink JR; Boer-Martins L; Gimpelewicz C; Davison BA; Wang Y; Voors AA; Severin T; Ponikowski P; Hua TA; Greenberg BH; Filippatos G; Felker GM; Cotter G; Metra M
    Am Heart J; 2017 May; 187():62-69. PubMed ID: 28454809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasodilators in acute heart failure - evidence based on new studies.
    Travessa AM; Menezes Falcão L
    Eur J Intern Med; 2018 May; 51():1-10. PubMed ID: 29482882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The RELAX-AHF study].
    Mortara A
    G Ital Cardiol (Rome); 2015 Apr; 16(4):193-7. PubMed ID: 25959752
    [No Abstract]   [Full Text] [Related]  

  • 38. Vasodilators in the treatment of acute heart failure: what we know, what we don't.
    Metra M; Teerlink JR; Voors AA; Felker GM; Milo-Cotter O; Weatherley B; Dittrich H; Cotter G
    Heart Fail Rev; 2009 Dec; 14(4):299-307. PubMed ID: 19096932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased mortality after an acute heart failure episode: new pathophysiological insights from the RELAX-AHF study and beyond.
    Cotter G; Milo O; Davison BA
    Curr Heart Fail Rep; 2014 Mar; 11(1):19-30. PubMed ID: 24363020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editor's Choice-Recent therapeutic trials on fluid removal and vasodilation in acute heart failure.
    Ennezat PV; Stewart M; Samson R; Bouabdallaoui N; Maréchaux S; Banfi C; Bouvaist H; Le Jemtel TH
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):86-95. PubMed ID: 25414321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.